InnoCare Pharma (HKSE:09969) Total Debt per Share : HK$0.77 (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is InnoCare Pharma Total Debt per Share?

HK$0.77 (As of Dec. 2024)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. InnoCare Pharma's Total Debt Per Share for the quarter that ended in Dec. 2024 was HK$0.77.

InnoCare Pharma Total Debt per Share Historical Data

The historical data trend for InnoCare Pharma's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InnoCare Pharma Total Debt per Share Chart

InnoCare Pharma Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Debt per Share

Get a 7-Day Free Trial

1.08

1.04

0.79

0.84

0.77

InnoCare Pharma Quarterly Data
	Dec17	Dec18	Sep19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Debt per Share	Get a 7-Day Free Trial														0.84	0.04	0.85	0.73	0.77

InnoCare Pharma Total Debt per Share Calculation

InnoCare Pharma's Total Debt Per Share for the fiscal year that ended in Dec. 2024 is calculated as:

Total Debt Per Share	=	(Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation)	/	Shares Outstanding (EOP)
	=	(1,117	+	241)	/	1,762
	=	0.77

InnoCare Pharma's Total Debt Per Share for the quarter that ended in Dec. 2024 is calculated as:

Total Debt Per Share	=	(Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation)	/	Shares Outstanding (EOP)
	=	(1,117	+	241)	/	1,762
	=	0.77

InnoCare Pharma Total Debt per Share Related Terms

Thank you for viewing the detailed overview of InnoCare Pharma's Total Debt per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

InnoCare Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InnoCare Pharma Ltd (HKSE:09969) » Definitions » Total Debt per Share

Comparable Companies

Traded in Other Exchanges

33C:Germany 688428:China

Address

No. 8 Life Science Park Road, Building 8, Zhongguancun Life Science Park, Changping District, Beijing, CHN, 102206

Website

https://www.innocarepharma.com

InnoCare Pharma Ltd is a commercial-stage biopharmaceutical company. It discovers, develops, and commercializes drugs for the treatment of cancer and autoimmune diseases. The company's main product pipeline includes orelabrutinib, ibrutinib, zanubrutinib, tafasitamab, ICP-490, ICP-B02, ICP-248, ICP-192, ICP-723, and ICP-189, among others. Its products are mainly used to treat hematological tumors, solid tumors, and autoimmune diseases. The company is also developing products for the treatment of autoimmune diseases caused by abnormal B-cell or T-cell function.

Executives

The Goldman Sachs Group, Inc.	2201 Interest of corporation controlled by you
Shi Yigong
Zhao Renbin
Sunny View Holdings Limited
Cui Jisong
King Bridge Investments Limited	2101 Beneficial owner
Pang Kee Chan Hebert	2201 Interest of corporation controlled by you
Gic Special Investments Private Limited	2102 Investment manager
Gic Private Limited	2201 Interest of corporation controlled by you
Gic (ventures) Pte. Ltd.	2201 Interest of corporation controlled by you
Hhlr Fund, L.p.	2101 Beneficial owner
Highbury Investment Pte Ltd	2201 Interest of corporation controlled by you
Hhlr Advisors, Ltd.	2102 Investment manager
Tmf (cayman) Ltd.	2301 Trustee
Sunland Biomed Ltd	2101 Beneficial owner

InnoCare Pharma Headlines

No Headlines